The Board

Born: 1955
Elected into the Board: 2017
Elected as Chair: 2019
Education: MBA from Handelshögskolan, Stockholm.
Experience: Senior Advisor for Patricia Industries AB since 2015. Previously, Managing Director (Business Development, Operational and Financial Investments) at Investor AB, and partner and CEO at Emerging Technologies ET AB and B-Business Partners.
Currently, Board member at Chalmers Ventures AB, Intervacc AB and GoCo Development AB.

Shareholding at December 31, 2024: 167,155 shares (own holding).

Born: 1956
Elected: 2016
Education: Ph.D. in Neuroscience from Karolinska Institutet, Stockholm.
Experience: Partner in Tellacq AB, a private investment company. Dr. Håkan Björklund has a long and successful career in the healthcare industry, including as CEO of Nycomed. Elected to the Board of Directors of BONESUPPORT in December 2016 in connection with the funding of USD 37 million (SEK 315 million), led by Tellacq.
Currently, Chair of the Board at Nordic Bioscience, BioPhorum, Asker Healthcare Group AB, Bohus BioTech AB and Intervacc AB.

Shareholding at December 31, 2024:-

Born: 1957
Elected: 2022
Education: MD. from Drexel University in Philadelphia and Orthopedic Residency and Fellowship at Mayo Clinic in Rochester.
Experience: Professor Emerita of Orthopedic Surgery at Mayo Clinic. Past, Professor of Orthopaedics and Rehabilitation at Yale University School of Medicine. Co-founder and Chief Medical Officer at Vori Health, a physician-led virtual musculoskeletal company. Honored with the American Academy of Orthopedic Surgery 2023 Diversity Award, Dr. Mary I O’Connor, MD., is a nationally recognized leader in health equity, chairing the Movement is Life Caucus, a nonprofit multi-stakeholder coalition committed to addressing musculoskeletal health disparities, since its inception in 2010.

Shareholding at December 31, 2024: 25,779 shares (own holding).

Born: 1958
Elected: 2010
Education: MD. Ph.D. from Karolinska Institutet in Stockholm.
Experience: Founder and Managing Partner of HealthCap. Previously headed the Health Care Team at ABB Aros. He has pursued scientific research in the biochemistry of inflammation at Karolinska Institutet.
Björn Odlander has extensive experience from Board assignments from listed and private companies in the life-science sector and is currently on the Boards of inter alia Oncorena AB and Tribune AB.

Shareholding at December 31, 2024: –

Born: 1964
Elected: 2022
Education: B.Sc. in Business Administration and Economics from Stockholm University.
Experience: Previously, Senior Vice President Corporate Control at Veoneer Inc., CFO at Cherry AB, acting CFO/Head of Finance at Serneke Group, Head of Corporate Control at Spotify and partner/Head of US Capital Markets in Sweden at PwC.
Currently, Board member at, among other assignments, Coinshares International Ltd, Orexo AB, 4C Group AB and Starbreeze AB. Previously, Board member at Adventure Box Technology AB and Technopolis Plc.

Shareholding at December 31, 2024: 2,335 shares (own holding).